🔗 Permalink

Inventor profile of:

Jeffery Fairman

City:

Mountain View, California

Country:

United States

Published Applications:

Last publication date:

2024-10-17

Top Assignees for applications by Jeffery Fairman

The entities that hold a legal rights for patent applications filed by inventor Fairman Jeffery:

Vaxcyte, Inc. 4 San Carlos, CA United States
Juvaris BioTherapeutics, Inc. 3 Burlingame, CA United States
SUTROVAX, INC. 2 Foster City, CA United States
Juvaris BioTherapeutics, Inc. 1 Pleasanton, CA United States
Colorado State University Research Foundation 1 Fort Collins, CO United States
Vaxcyte, Inc. 1 Foster City, CA United States
The Trustees of the University of Pennslyvania 1 Philadelphia, PA United States
Juvaris Bio Therapeutics, Inc. 1 Burlingame, CA United States

Recent patent applications by Fairman Jeffery

Jeffery Fairman from Mountain View, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-10-17

US20240342274A1

Human necessities

POLYPEPTIDE-ANTIGEN CONJUGATES WITH NON-NATURAL AMINO ACIDS

#2 | 2024-07-11

US20240226259A9

Human necessities

PERIODONTITIS VACCINE AND RELATED COMPOSITIONS AND METHODS OF USE

#3 | 2024-04-25

US20240131134A1

Human necessities

Periodontitis vaccine and related compositions and methods of use

#4 | 2021-11-25

US20210361756A1

Human necessities

Periodontitis vaccine and related compositions and methods of use

#5 | 2019-06-27

US20190192645A1

Human necessities

Periodontitis vaccine and related compositions and methods of use

#6 | 2018-11-22

US20180333484A1

Human necessities

Polypeptide-antigen conjugates with non-natural amino acids

#7 | 2013-07-04

US20130171234A1

Human necessities

Subunit vaccines for herpes viruses and methods of use

#8 | 2010-04-08

US20100086584A1

Human necessities

VACCINE COMPOSITIONS OF M2e, HA0 AND BM2 MULTIPLE ANTIGENIC PEPTIDES

#9 | 2009-10-22

US20090263423A1

Human necessities

Enhancement of an immune response by administration of a cationic lipid-DNA complex (CLDC)

#10 | 2009-07-02

US20090169612A1

Human necessities

Systemic Immune Activation Method Using Nucleic Acid-Lipid Complexes

#11 | 2005-08-18

US20050181035A1

Human necessities

Systemic immune activation method using non CpG nucleic acids

#12 | 2005-01-20

US20050013812A1

Human necessities

Vaccines using pattern recognition receptor-ligand:lipid complexes

InventorID:

323510 ⎘